FECH

ferrochelatase

Basic information

Region (hg38): 18:57544377-57586732

Links

ENSG00000066926NCBI:2235OMIM:612386HGNC:3647Uniprot:P22830AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • protoporphyria, erythropoietic, 1 (Strong), mode of inheritance: AR
  • autosomal erythropoietic protoporphyria (Supportive), mode of inheritance: AD
  • protoporphyria, erythropoietic, 1 (Definitive), mode of inheritance: AR
  • protoporphyria, erythropoietic, 1 (Strong), mode of inheritance: AR
  • protoporphyria, erythropoietic, 1 (Definitive), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Protoporphyria, erythropoietic 1AD/ARDermatologic; GastrointestinalWhile the only manifestation in many individuals is photosensitivity (for which light avoidance and possible medical treatment, such as with alpha-melanocyte-stimulating hormone analog, can be beneficial), some individuals can have severe liver sequelae, and surveillance and medical treatment (eg, with cholestyramine) can be beneficial; BMT and liver transplantation may be necessaryDermatologic; Gastrointestinal; Hematologic14072370; 5835322; 14338805; 6019665; 5536249; 1138541; 1251847; 911406; 3805002; 6742776; 2384686; 1755842; 8571955; 8601739; 9649563; 9585598; 11039124; 11753383; 12601550; 16385445; 17875872; 19144952; 18787536; 19744342; 20857522; 21659066; 22971305; 23016163; 23323258; 23600449; 37043653
The inheritance pattern can be complex, and can involve a deleterious variant in trans with a "low-normal" polymorphism (sometimes termed "pseudodominant" inheritance), as well as homozygosity/compound heterozygosity for deleterious variants; Agents associated with hepatic dysfunction should be avoided

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the FECH gene.

  • not provided (32 variants)
  • Protoporphyria, erythropoietic, 1 (10 variants)
  • FECH-related disorder (1 variants)
  • See cases (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the FECH gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
18
clinvar
5
clinvar
23
missense
2
clinvar
6
clinvar
50
clinvar
5
clinvar
2
clinvar
65
nonsense
8
clinvar
1
clinvar
1
clinvar
10
start loss
1
clinvar
1
frameshift
12
clinvar
2
clinvar
14
inframe indel
0
splice donor/acceptor (+/-2bp)
8
clinvar
5
clinvar
1
clinvar
14
splice region
2
8
13
23
non coding
49
clinvar
55
clinvar
50
clinvar
154
Total 30 14 101 79 57

Highest pathogenic variant AF is 0.0000657

Variants in FECH

This is a list of pathogenic ClinVar variants found in the FECH region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
18-57544911-A-C Protoporphyria, erythropoietic, 1 Likely benign (Jun 14, 2016)327315
18-57545084-G-T Protoporphyria, erythropoietic, 1 Benign (Jun 14, 2016)327316
18-57545124-C-T Protoporphyria, erythropoietic, 1 Benign (Jun 14, 2016)327317
18-57545318-C-A Protoporphyria, erythropoietic, 1 Likely benign (Jun 14, 2016)327318
18-57545363-G-A Protoporphyria, erythropoietic, 1 Uncertain significance (Jun 14, 2016)327319
18-57545465-A-G Protoporphyria, erythropoietic, 1 Uncertain significance (Jun 14, 2016)327320
18-57545542-A-G Protoporphyria, erythropoietic, 1 Uncertain significance (Jun 14, 2016)327321
18-57545569-G-A Protoporphyria, erythropoietic, 1 Likely benign (Jun 14, 2016)327322
18-57545572-C-T Protoporphyria, erythropoietic, 1 Likely benign (Jun 14, 2016)327323
18-57545573-G-A Protoporphyria, erythropoietic, 1 Likely benign (Jun 14, 2016)327324
18-57545622-C-T Protoporphyria, erythropoietic, 1 Uncertain significance (Jun 14, 2016)327325
18-57545741-T-C Protoporphyria, erythropoietic, 1 Benign (Jun 14, 2016)327326
18-57545820-C-CA Protoporphyria, erythropoietic, 1 Benign (Jun 14, 2016)327327
18-57545826-A-C Protoporphyria, erythropoietic, 1 Benign (Jun 14, 2016)327328
18-57545828-A-AG Protoporphyria, erythropoietic, 1 Likely benign (Jun 14, 2016)327329
18-57545883-G-A Protoporphyria, erythropoietic, 1 Likely benign (Jun 14, 2016)327330
18-57545913-TTAA-T Protoporphyria, erythropoietic, 1 Likely benign (Jun 14, 2016)327331
18-57545992-A-G Protoporphyria, erythropoietic, 1 Uncertain significance (Jun 14, 2016)327332
18-57546114-A-C Protoporphyria, erythropoietic, 1 Uncertain significance (Jun 14, 2016)327333
18-57546115-A-G Protoporphyria, erythropoietic, 1 Likely benign (Jun 14, 2016)327334
18-57546149-C-A Protoporphyria, erythropoietic, 1 Benign (Jun 14, 2016)327335
18-57546184-G-A Protoporphyria, erythropoietic, 1 Uncertain significance (Jun 14, 2016)327336
18-57546249-T-C Protoporphyria, erythropoietic, 1 Benign (Jun 14, 2016)327337
18-57546254-G-A Protoporphyria, erythropoietic, 1 Likely benign (Jun 14, 2016)327338
18-57546263-T-C Protoporphyria, erythropoietic, 1 Uncertain significance (Jun 14, 2016)327339

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
FECHprotein_codingprotein_codingENST00000382873 1138490
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.002760.9971257260221257480.0000875
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.341752320.7530.00001272790
Missense in Polyphen6691.4790.721471097
Synonymous0.6478390.80.9140.00000574827
Loss of Function3.03925.50.3530.00000136287

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0002130.000213
Ashkenazi Jewish0.000.00
East Asian0.000.00
Finnish0.00004620.0000462
European (Non-Finnish)0.0001410.000141
Middle Eastern0.000.00
South Asian0.00003270.0000327
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the ferrous insertion into protoporphyrin IX.;
Disease
DISEASE: Protoporphyria, erythropoietic, 1 (EPP1) [MIM:177000]: An autosomal recessive form of porphyria with onset usually before age 10 years. Porphyrias are inherited defects in the biosynthesis of heme, resulting in the accumulation and increased excretion of porphyrins or porphyrin precursors. They are classified as erythropoietic or hepatic, depending on whether the enzyme deficiency occurs in red blood cells or in the liver. Erythropoietic protoporphyria is marked by excessive protoporphyrin in erythrocytes, plasma, liver and feces, and by widely varying photosensitive skin changes ranging from a burning or pruritic sensation to erythema, edema and wheals. {ECO:0000269|PubMed:10942404, ECO:0000269|PubMed:11375302, ECO:0000269|PubMed:12063482, ECO:0000269|PubMed:12601550, ECO:0000269|PubMed:1376018, ECO:0000269|PubMed:15286165, ECO:0000269|PubMed:17196862, ECO:0000269|PubMed:1755842, ECO:0000269|PubMed:7910885, ECO:0000269|PubMed:8757534, ECO:0000269|PubMed:9211198, ECO:0000269|PubMed:9585598, ECO:0000269|PubMed:9740232}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Pathway
Porphyrin and chlorophyll metabolism - Homo sapiens (human);Hereditary Coproporphyria (HCP);Porphyria Variegata (PV);Congenital Erythropoietic Porphyria (CEP) or Gunther Disease;Acute Intermittent Porphyria;Porphyrin Metabolism;Heme Biosynthesis;hemoglobins chaperone;Heme biosynthesis;Metabolism of porphyrins;Metabolism;Porphyrin metabolism;Porphyrin metabolism;HIF-1-alpha transcription factor network;heme biosynthesis from uroporphyrinogen-III I;heme biosynthesis (Consensus)

Recessive Scores

pRec
0.303

Intolerance Scores

loftool
0.0817
rvis_EVS
0.04
rvis_percentile_EVS
57.31

Haploinsufficiency Scores

pHI
0.438
hipred
Y
hipred_score
0.589
ghis
0.396

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
S
essential_gene_gene_trap
K
gene_indispensability_pred
E
gene_indispensability_score
0.986

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Fech
Phenotype
integument phenotype (the observable morphological and physiological characteristics of the skin and its associated structures, such as the hair, nails, sweat glands, sebaceous glands and other secretory glands that are manifested through development and lifespan); growth/size/body region phenotype; adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); homeostasis/metabolism phenotype; liver/biliary system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); hematopoietic system phenotype; immune system phenotype;

Zebrafish Information Network

Gene name
fech
Affected structure
nucleate erythrocyte
Phenotype tag
abnormal
Phenotype quality
increased fluorescence

Gene ontology

Biological process
generation of precursor metabolites and energy;heme biosynthetic process;response to light stimulus;response to lead ion;response to insecticide;response to ethanol;protoporphyrinogen IX metabolic process;response to arsenic-containing substance;response to methylmercury;response to platinum ion;cellular response to dexamethasone stimulus
Cellular component
mitochondrion;mitochondrial inner membrane;mitochondrial matrix
Molecular function
ferrochelatase activity;protein binding;ferrous iron binding;2 iron, 2 sulfur cluster binding